Loading...
ROCO
4102
Market cap27mUSD
Jul 09, Last price  
20.50TWD
1D
0.49%
1Q
6.22%
Jan 2017
19.88%
IPO
22.68%
Name

Yung Zip Chemical Ind Co Ltd

Chart & Performance

D1W1MN
ROCO:4102 chart
P/E
P/S
1.83
EPS
Div Yield, %
5.61%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
0.47%
Revenues
474m
-18.76%
416,837,000463,212,000477,595,000567,331,000559,154,000583,695,000474,221,000
Net income
-14m
L
31,319,00030,742,0006,004,00069,993,00062,506,00064,605,000-14,364,000
CFO
2m
-98.23%
30,756,00036,067,00073,266,00092,553,00096,760,000118,671,0002,096,000
Dividend
Jul 04, 20251.15 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yung Zip Chemical Ind. Co., Ltd. is a global provider specializing in the manufacture of essential pharmaceutical components. The company supplies active pharmaceutical ingredients (APIs), their intermediate precursors, and various specialty chemicals to markets around the world. Their diverse product portfolio includes a wide array of therapeutic agents addressing conditions such as hypertension, iron overload, inflammation, pain, fever, fungal infections, schizophrenia, blood clotting issues, genital herpes outbreaks, and sleep disorders (hypnotics and sedatives). In addition to these core offerings, Yung Zip also provides pharmaceutical excipients, such as sodium starch glycolate, and offers bespoke research, development, and manufacturing services. The company, established in 1978, is headquartered in Taichung, Taiwan.
IPO date
Mar 20, 2001
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT